Position in ETON
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$622,640
+$252,440 QoQ
Shares Held
17,200
+14.7% QoQ
Ownership
0.060%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#79
of 163 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ETON Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026BANK OF NOVA SCOTIA holds $34,652,219 across 6 Drug Manufacturers - Specialty & Generic names. ETON ranks #5 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VTRS |
Viatris Inc
|
1,771,440 | $28,130,467 | |
| 2 | ZTS |
Zoetis Inc.
|
44,160 | $3,173,337 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
2,315 | $1,254,336 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
5,822 | $981,239 | |
| 5 | ETON |
Eton Pharmaceuticals, Inc.
This page
|
17,200 | $622,640 | |
| 6 | BIOA |
BioAge Labs, Inc.
|
20,000 | $490,200 |
All Filings in ETON
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $622,640 | 17,200 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $370,200 | 15,000 | Shares | Sole | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||